Clinical Trials Browser

Withdrawn × INDUSTRY × exemestane × Clear all

NCT00615524 2018-01-12

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT01658176 2012-10-29

Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms